Keywords
chondroitin; chondroitin sulfate; chondroprotective agent; glucosamine; glycosaminoglycan; hyaluronic acid; chondroprotection; clinical effectiveness; diet supplementation; drug half life; human; hydrolysis; letter; nonhuman; osteoarthritis; priority journal; synovial fluid; viscosity; Animals; Dietary Supplements; Evidence-Based Medicine; Glycosaminoglycans; Humans; Osteoarthritis; Treatment Outcome; Viscosupplementation; Viscosupplements